Inari Revenue and Competitors
Estimated Revenue & Valuation
- Inari's estimated annual revenue is currently $198.4M per year.
- Inari received $40.0M in venture funding in August 2018.
- Inari's estimated revenue per employee is $302,439
- Inari's total funding is $771M.
- Inari's current valuation is $1.2B.
Employee Data
- Inari has 656 Employees.
- Inari grew their employee count by 10% last year.
Inari's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO & Director | Reveal Email/Phone |
2 | Scientific Co-Founder | Reveal Email/Phone |
3 | VP data and ML | Reveal Email/Phone |
4 | SVP, People | Reveal Email/Phone |
5 | VP Finance, FP&A and Treasury | Reveal Email/Phone |
6 | VP Late Product Development | Reveal Email/Phone |
7 | VP, Assistant General Counsel | Reveal Email/Phone |
8 | Head Government Affairs | Reveal Email/Phone |
9 | VP, Capital Markets/Investor Relations | Reveal Email/Phone |
10 | VP, Corporate Affairs | Reveal Email/Phone |
Inari Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $139.1M | 412 | 12% | N/A | N/A |
#2 | $16.1M | 111 | -13% | $29.5M | N/A |
#3 | $32.3M | 245 | 3% | N/A | N/A |
#4 | $57.4M | 353 | -1% | N/A | N/A |
What Is Inari?
Inari embraces diversity in every aspect of our business to drive innovation and help build a new food system. Our technology matches the complexity of nature to transform seed using predictive design and multiplex gene editing – unlocking the full potential through our SEEDesign™ platform. The result is step-change products that lead to more productive acres and a more sustainable future for the food system.
keywords:Agriculture, Technology
$771M
Total Funding
656
Number of Employees
$198.4M
Revenue (est)
10%
Employee Growth %
$1.2B
Valuation
N/A
Accelerator
Inari News
By Stephen Nakrosis. Shares of Inari Medical Inc. and Tri Pointe Homes Inc. are higher in Thursday's late-trading session, following news...
("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous diseases,...
Analysts expect the company to announce earnings of ($0.08) per share for the quarter. Inari Medical has set its FY 2022 guidance at EPS.
Inari, a Cambridge, Mass.-based deveoper of a platform to enable yield increase, raised $208m in Series D funding. The round, which brought cumulative equity raised to more than $352m, was co-led by Flagship Pioneering with participation from Alexandria Venture Investments, Investment Corporati ...
CAMBRIDGE, Mass., Jan. 5, 2021 /PRNewswire/ -- Inari, a biotech seed company, today announced that Bob Bechek has been appointed to its board of directors. Bechek is a partner and former worldwide managing director (CEO) and board chair of consulting firm Bain & Company. His appointment, effe ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $182.1M | 662 | 9% | N/A |
#2 | $67.7M | 670 | 1% | $689M |
#3 | $104.6M | 675 | 33% | N/A |
#4 | $121.6M | 684 | -12% | $481M |
#5 | $101.1M | 708 | 27% | N/A |
Inari Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2018-08-10 | $40.0M | B | Acre Venture Partners | Article |